vs
ACCESS Newswire Inc.（ACCS）与Vivos Therapeutics, Inc.（VVOS）财务数据对比。点击上方公司名可切换其他公司
ACCESS Newswire Inc.的季度营收约是Vivos Therapeutics, Inc.的1.5倍（$5.8M vs $3.8M），ACCESS Newswire Inc.净利率更高（-9.9% vs -180.3%，领先170.3%），Vivos Therapeutics, Inc.同比增速更快（3.4% vs -0.5%），过去两年Vivos Therapeutics, Inc.的营收复合增速更高（5.8% vs 2.0%）
ACCESS通讯社是一家新闻通稿分发服务商，总部位于芝加哥，1954年成立，最初通过电传设备为企业向新闻机构电子传输新闻稿，创始人赫伯特·穆舍勒曾在曼哈顿家中运营该业务长达15年，公司几经转手后，于2015年被Cision集团宣布收购。
Beam Therapeutics是一家总部位于美国马萨诸塞州剑桥市的美国生物技术企业，专注于基因疗法与基因编辑领域的研发工作。公司依托CRISPR碱基编辑和引导编辑技术开发疗法，可在不产生DNA双链断裂的情况下，对DNA序列中的单个核苷酸进行酶修饰。
ACCS vs VVOS — 直观对比
营收规模更大
ACCS
是对方的1.5倍
$3.8M
营收增速更快
VVOS
高出3.9%
-0.5%
净利率更高
ACCS
高出170.3%
-180.3%
两年增速更快
VVOS
近两年复合增速
2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.8M | $3.8M |
| 净利润 | $-576.0K | $-6.9M |
| 毛利率 | 77.4% | 78.1% |
| 营业利润率 | -13.1% | -166.8% |
| 净利率 | -9.9% | -180.3% |
| 营收同比 | -0.5% | 3.4% |
| 净利润同比 | 94.4% | -143.8% |
| 每股收益（稀释后） | $-0.16 | $-0.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACCSVVOS
| Q4 25 | $5.8M | $3.8M | ||
| Q3 25 | $5.7M | $6.8M | ||
| Q2 25 | $5.6M | $3.8M | ||
| Q1 25 | $5.5M | $3.0M | ||
| Q4 24 | $5.8M | $3.7M | ||
| Q3 24 | $5.6M | $3.9M | ||
| Q2 24 | $6.0M | $4.1M | ||
| Q1 24 | $5.6M | $3.4M |
净利润ACCSVVOS
| Q4 25 | $-576.0K | $-6.9M | ||
| Q3 25 | $-45.0K | $-5.4M | ||
| Q2 25 | $-475.0K | $-5.0M | ||
| Q1 25 | $5.4M | $-3.9M | ||
| Q4 24 | $-10.2M | $-2.8M | ||
| Q3 24 | $-466.0K | $-2.6M | ||
| Q2 24 | $7.0K | $-1.9M | ||
| Q1 24 | $-139.0K | $-3.8M |
毛利率ACCSVVOS
| Q4 25 | 77.4% | 78.1% | ||
| Q3 25 | 74.6% | 58.0% | ||
| Q2 25 | 76.2% | 55.2% | ||
| Q1 25 | 78.0% | 50.0% | ||
| Q4 24 | 75.2% | 56.7% | ||
| Q3 24 | 75.0% | 60.5% | ||
| Q2 24 | 77.2% | 65.4% | ||
| Q1 24 | 75.1% | 56.7% |
营业利润率ACCSVVOS
| Q4 25 | -13.1% | -166.8% | ||
| Q3 25 | -3.2% | -69.8% | ||
| Q2 25 | -4.4% | -127.4% | ||
| Q1 25 | -12.4% | -129.9% | ||
| Q4 24 | -245.8% | -75.9% | ||
| Q3 24 | -10.7% | -68.5% | ||
| Q2 24 | -8.8% | -47.8% | ||
| Q1 24 | -15.5% | -110.7% |
净利率ACCSVVOS
| Q4 25 | -9.9% | -180.3% | ||
| Q3 25 | -0.8% | -79.6% | ||
| Q2 25 | -8.5% | -131.2% | ||
| Q1 25 | 98.4% | -128.1% | ||
| Q4 24 | -175.0% | -76.4% | ||
| Q3 24 | -8.3% | -67.8% | ||
| Q2 24 | 0.1% | -47.6% | ||
| Q1 24 | -2.5% | -110.1% |
每股收益（稀释后）ACCSVVOS
| Q4 25 | $-0.16 | $-0.58 | ||
| Q3 25 | $-0.01 | $-0.49 | ||
| Q2 25 | $-0.12 | $-0.55 | ||
| Q1 25 | $1.40 | $-0.45 | ||
| Q4 24 | $-2.66 | $0.41 | ||
| Q3 24 | $-0.12 | $-0.40 | ||
| Q2 24 | $0.00 | $-0.60 | ||
| Q1 24 | $-0.04 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $2.0M |
| 总债务越低越好 | — | $2.9M |
| 股东权益账面价值 | $30.3M | $-1.5M |
| 总资产 | $42.0M | $25.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACCSVVOS
| Q4 25 | $3.0M | $2.0M | ||
| Q3 25 | $3.3M | $3.1M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | $4.1M | $6.3M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $6.9M | ||
| Q1 24 | — | $2.6M |
总债务ACCSVVOS
| Q4 25 | — | $2.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $1.2M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | — |
股东权益ACCSVVOS
| Q4 25 | $30.3M | $-1.5M | ||
| Q3 25 | $30.8M | $2.5M | ||
| Q2 25 | $30.7M | $4.6M | ||
| Q1 25 | $30.9M | $4.4M | ||
| Q4 24 | $25.2M | $8.0M | ||
| Q3 24 | $35.3M | $7.7M | ||
| Q2 24 | $35.4M | $6.3M | ||
| Q1 24 | $35.2M | $582.0K |
总资产ACCSVVOS
| Q4 25 | $42.0M | $25.2M | ||
| Q3 25 | $44.0M | $25.6M | ||
| Q2 25 | $45.6M | $26.0M | ||
| Q1 25 | $47.3M | $11.3M | ||
| Q4 24 | $50.6M | $15.3M | ||
| Q3 24 | $61.7M | $15.3M | ||
| Q2 24 | $62.8M | $15.8M | ||
| Q1 24 | $64.4M | $11.8M |
负债/权益比ACCSVVOS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.19× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $258.0K | $-3.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-5.3M |
| 自由现金流率自由现金流/营收 | — | -139.7% |
| 资本支出强度资本支出/营收 | 0.0% | 40.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-17.8M |
8季度趋势，按日历期对齐
经营现金流ACCSVVOS
| Q4 25 | $258.0K | $-3.8M | ||
| Q3 25 | $-582.0K | $-4.2M | ||
| Q2 25 | $135.0K | $-3.5M | ||
| Q1 25 | $747.0K | $-3.8M | ||
| Q4 24 | $866.0K | $-2.9M | ||
| Q3 24 | $1.5M | $-4.2M | ||
| Q2 24 | $-190.0K | $-3.0M | ||
| Q1 24 | $986.0K | $-2.5M |
自由现金流ACCSVVOS
| Q4 25 | — | $-5.3M | ||
| Q3 25 | $-590.0K | $-4.2M | ||
| Q2 25 | — | $-4.3M | ||
| Q1 25 | $735.0K | $-3.9M | ||
| Q4 24 | — | $-3.1M | ||
| Q3 24 | $1.5M | $-4.4M | ||
| Q2 24 | — | $-3.1M | ||
| Q1 24 | $970.0K | $-2.7M |
自由现金流率ACCSVVOS
| Q4 25 | — | -139.7% | ||
| Q3 25 | -10.3% | -62.6% | ||
| Q2 25 | — | -111.6% | ||
| Q1 25 | 13.4% | -129.9% | ||
| Q4 24 | — | -84.0% | ||
| Q3 24 | 26.5% | -113.4% | ||
| Q2 24 | — | -76.7% | ||
| Q1 24 | 17.4% | -78.0% |
资本支出强度ACCSVVOS
| Q4 25 | 0.0% | 40.0% | ||
| Q3 25 | 0.1% | 1.2% | ||
| Q2 25 | 0.0% | 20.2% | ||
| Q1 25 | 0.2% | 4.0% | ||
| Q4 24 | 0.0% | 4.5% | ||
| Q3 24 | 0.1% | 5.0% | ||
| Q2 24 | 0.0% | 1.5% | ||
| Q1 24 | 0.3% | 4.4% |
现金转化率ACCSVVOS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -27.14× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACCS
| Cost To Deliver Products | $3.1M | 54% |
| Employee Costs | $1.7M | 29% |
| Other | $1.0M | 17% |
VVOS
| Services | $3.2M | 84% |
| Products | $594.0K | 16% |
